Pathogens and Disease ISSN 2049-632X
EDITORIAL
Emerging infections, biosecurity and public health DOI: 10.1111/2049-632X.12198
The NIH issued an initiative in 2002 to construct new laboratories designed to safely handle high-containment pathogens at biosafety level 3 (BSL-3)/animal biosafety level 3 (ABSL-3) and BSL-4/ABSL-4. This initiative was largely a joint venture between the NIH and academic institutions, resulting in several large high-containment facilities throughout the USA that are now fully constructed, commissioned, and operational. Scientists in these facilities are working together with other academic institutions as well as with corporate entities to reduce the impact of emerging infections and biothreats in our world. The contributions in this special issue highlight the technologies, pathogens, and scope of work that is being performed in these high-containment laboratories and demonstrate the basis for scientific growth and expansion over the next 20 years.
We, the guest editors, would like to thank all the contributing authors and institutions for their time and effort in making this a successful edition. We would also like to thank Dr Patrik Bavoil, Chief Editor, and Ms Gillian van Beest, Editorial Administrator, for their unwavering assistance and support on this special issue of Pathogens and Disease. Gerald Byrne University of Tennessee Health Sciences Center, Memphis, TN, USA E-mail: [email protected] Kelly Stefano Cole University of Pittsburgh Center for Vaccine Research, Pittsburgh, PA, USA E-mail: [email protected]
Pathogens and Disease (2014), 71, 93, © 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved
93
Copyright of Pathogens & Disease is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
EDITORIAL
Emerging infections, biosecurity and public health DOI: 10.1111/2049-632X.12198
The NIH issued an initiative in 2002 to construct new laboratories designed to safely handle high-containment pathogens at biosafety level 3 (BSL-3)/animal biosafety level 3 (ABSL-3) and BSL-4/ABSL-4. This initiative was largely a joint venture between the NIH and academic institutions, resulting in several large high-containment facilities throughout the USA that are now fully constructed, commissioned, and operational. Scientists in these facilities are working together with other academic institutions as well as with corporate entities to reduce the impact of emerging infections and biothreats in our world. The contributions in this special issue highlight the technologies, pathogens, and scope of work that is being performed in these high-containment laboratories and demonstrate the basis for scientific growth and expansion over the next 20 years.
We, the guest editors, would like to thank all the contributing authors and institutions for their time and effort in making this a successful edition. We would also like to thank Dr Patrik Bavoil, Chief Editor, and Ms Gillian van Beest, Editorial Administrator, for their unwavering assistance and support on this special issue of Pathogens and Disease. Gerald Byrne University of Tennessee Health Sciences Center, Memphis, TN, USA E-mail: [email protected] Kelly Stefano Cole University of Pittsburgh Center for Vaccine Research, Pittsburgh, PA, USA E-mail: [email protected]
Pathogens and Disease (2014), 71, 93, © 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved
93
Copyright of Pathogens & Disease is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
